Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noninvasive Biomarkers in Pediatric Eosinophilic Esophagitis
NCT06387030Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Urinary Eosinophil-Derived Neurotoxin Concentration at 4 months. Started Apr 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06387030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387030.